The largest database of trusted experimental protocols

7 protocols using nr 52511

1

Diverse Cell Lines for Coronavirus Propagation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human rhabdomyosarcoma cell line (RD, ATCC® CCL-136™), African green monkey kidney cell line Vero C1008 (ATCC® CRL-1586™), Human hepatoma cell line Huh-7 (a kind gift from Dr. Tianyi Wang at University of Pittsburgh), and HEK293T expressing ACE2 (293T-ACE2, BEI Resources, NR-52511) cell lines were maintained in Dulbecco’s modified eagle’s medium (DMEM); Human fibroblast cell line MRC-5 (ATCC® CCL-171™), Human lung adenocarcinoma cell line Calu-3 (ATCC® HTB-55™), human Colorectal adenocarcinoma cell line (Caco-2, ATCC® HTB-37™) were maintained in eagle’s minimum essential medium (EMEM, ATCC® 30-2003™). Both media were supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin antibiotics. Cells were kept at cell culture incubator (humidified, 5% CO2/95% air, 37 °C). The following reagents were obtained through BEI Resources, NIAID, NIH: human coronavirus, HCoV-OC43, NR-52725; human coronavirus, HCoV-NL63, NR-470. HCoV-OC43 was propagated in RD cell line; HCoV-NL63 was initially propagated in 293T-ACE2 cell line and accommodated in Vero E6 cell line. HCoV-229E was obtained from Dr. Bart Tarbet (Utah State University) and amplified in Huh-7 or MRC-5 cell lines.
+ Open protocol
+ Expand
2

SARS-CoV-2 Spike Pseudotype Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 spike-pseudotyped lentivirus-neutralization assays were performed as previously described30 (link), with the following slight modifications. Infections were carried out in poly-l-lysine- (P4707, Millipore Sigma, Burlington, MA, USA) coated black-walled, clear-bottom plates (655090, Greiner Bio-One, Kremsmünster, Austria), and luciferase activity was measured in these plates without transferring to opaque-bottom plates. Sera were diluted 3-fold 7 times starting at a 1:25 dilution, and luciferase activity was measured at 52 h post infection. Target cells were HEK-293T cells transduced to express hACE230 (link) (BEI Resources, NR-52511). Samples were run in duplicate, and each plate included two no-serum controls. Fraction infectivity was calculated by normalizing the luciferase reading for each sample by the average of the two no-serum control wells in the same row. Neutralization curves were plotted using the neutcurve Python package (https://jbloomlab.github.io/neutcurve/, 0.3.1). This package fits a three-parameter Hill curve, with the top baseline fixed to one and the bottom baseline fixed to zero. The neutralization curves are shown in Supplementary Fig. 1.
+ Open protocol
+ Expand
3

SARS-CoV-2 Infection Model in ACE2-Expressing Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vero E6 and HEK 293T cells expressing human ACE2 cells (NR-52511, BEI Resources, NIAID, NIH, RRID: CVCL_A7UK) were cultured in complete media containing Dulbecco’s modified Eagle medium (#CC3004, Cell Clone, Genetix, New Delhi, India) with 10% CELLECT FBS GOLD (#2916754, MP Biomedicals, Santa Ana, CA, USA), 100 IU/mL Penicillin, 100 μg/mL Streptomycin, and 0.25 μg/mL Amphotericin-B (Antibiotic-Antimycotic Solution, #A5955, Sigma-Aldrich, St. Louis, MO, USA).
SARS-CoV-2 isolates (Hong Kong/VM20001061/2020, NR-52282; hCoV-19/USA/MD-HP05285/2021, NR-55671 (Delta Variant)) were obtained from BEI Resources, the NIAID, and the NIH and were propagated and tittered by using standard plaque assay in Vero E6 cells. The Omicron variant was isolated from the patient sample from the South Karnataka region, India, and was confirmed using S gene target failure PCR. All the experiments pertaining to live SARS-CoV-2 were performed in a viral biosafety level 3 laboratory at CIDR, IISc, Bangalore.
+ Open protocol
+ Expand
4

Maintenance of HEK293T and HEK293T-ACE2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells (CRL-11268, CVCL_1926, ATCC, Manassas, VA) and HEK293T-ACE2 cells (NR-52511, BEI Resources, ATCC, Manassas, VA) were maintained in Dulbeco’s Modified Eagles Medium (Gibco, 11965–092, ThermoFisher Scientific, Waltham, MA) supplemented with 10% (v/v) fetal bovine serum (F1051, Sigma-Aldrich, St. Louis, MO) and 1% (v/v) penicillin/streptomycin (SV30010, HyClone Laboratories Inc., Logan, UT). Cells were maintained in at 37°C and 5% CO2.
+ Open protocol
+ Expand
5

Cell Culture of Human Derived Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines were incubated at 37°C in the presence of 5% CO2. 293-6E (human female, RRID:CVCL_HF20) and 293T cells (human female, RRID:CVCL_0063) cells were maintained in Freestyle 293 media with gentle shaking. HEK-293T-hACE2 (human female, BEI Resources Cat# NR-52511) were maintained in DMEM containing 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (cDMEM).
+ Open protocol
+ Expand
6

SARS-CoV-2 Propagation and Titration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Authenticated (relevant documentation regarding authentication by suppliers is available in Supplemental Data) HEK 293T cells expressing human ACE2 (NR-52511, BEI Resources, NIAID, NIH, RRID: CVCL_A7UK) and VeroE6 cells (CRL-1586, ATCC, RRID:CVCL_0574) were cultured in complete media containing Dulbecco's modified Eagle medium (12100-038, Gibco) with 10% HI-FBS (16140-071, Gibco), 100 IU/ml Penicillin, 100 μg/ml Streptomycin and 0.25μg/ml Amphotericin-B (Penicillin-Streptomycin-Amphotericin B, ICN1674049, MP Biomedicals) supplemented with GlutaMAX™ (35050-061, Gibco). SARS-CoV2 (Isolate Hong Kong/VM20001061/2020, NR-52282, BEI Resources, NIAID, NIH) was propagated and titered by plaque assay in Vero E6 cells as described before [19] (link).
+ Open protocol
+ Expand
7

SARS-CoV-2 Entry Receptor Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following cell lines were used in this study, namely, HEK293 (ATCC), HEK293T-ACE2 (HEK293T cells stably expressing human angiotensin-converting enzyme 2) (BEI Resources NR-52511, NIAID, NIH. RRID: CVCL_A7UK) and Vero-E6 cells (CRL-1586, ATCC, RRID: CVCL_0574). The authenticity of HEK293T-ACE2 and Vero-E6 cell lines was confirmed by Certificate of Analysis from their respective sources. HEK293T-ACE2 are human embryonic kidney 293T cells that express the human ACE2 receptor, which is required for SARS-CoV-2 entry. HEK293T-ACE2 and Vero E6 cells are of human and primate origin respectively, and express ACE2 receptor. All cell lines tested negative for mycoplasma contamination. Cells were cultured in complete media prepared using Dulbecco’s modified Eagle medium (12100–038, Gibco) supplemented with 10% HI-FBS (16140–071, Gibco), 100 U/mL Penicillin-Streptomycin (15140122, Gibco) and GlutaMAX (35050–061, Gibco).
SARS-CoV2 (Isolate Hong Kong/VM20001061/2020, NR-52282, BEI Resources, NIAID, NIH) was propagated and quantified by plaque assay in Vero-E6 cells as described before (Case et al., 2020 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!